RBayliss2023 Profile Banner
Dr Rebecca Bayliss Profile
Dr Rebecca Bayliss

@RBayliss2023

Followers
40
Following
411
Media
3
Statuses
249

Cardiff, Wales
Joined September 2023
Don't wanna be here? Send us removal request.
@RBayliss2023
Dr Rebecca Bayliss
4 months
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies @emilyanne611 Interested in contributing? Please submit an abstract here:
0
1
5
@ResearchWales
Health and Care Research Wales
5 days
Congratulations to @alanlparker, Health and Care Research Wales Senior Research Leader, on winning the 2026 Translational Microbiology Prize from @MicrobioSoc. Find out more. #ResearchWalesFaculty https://t.co/BCR745ihPZ
0
3
11
@MicrobioSoc
Microbiology Society
6 days
@UniofNottingham @DrToniHo @CVRinfo @Edel_PLopez @universitelaval @bfrancescol @uff_br @UofT @UWMadison @rfsuny Marjory Stephenson Prize 2026: Professor Mark Buttner — @JohnInnesCentre Outreach and Engagement Prize 2026: @LindsayBbent@UniOfSurrey Translational Microbiology Prize 2026: @alanlparker@thewcrc
0
1
6
@alanlparker
Alan Parker
2 months
Check out our new structural work, including a 3.3Å resolution of the whole Ad10 capsid, and a 4.6Å resolution of the fiber shaft. Identification of a novel structural motif and overexpression of key transcripts elucidated in Adenovirus 10
Tweet card summary image
biorxiv.org
Adenoviruses are widely used as vectors for subunit vaccines and oncolytic therapies. Efficient vectors must infect target cells and deliver therapeutic transgenes at high levels. Species D adenovi...
0
5
5
@MolTherapy
Molecular Therapy Family of Journals
2 months
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer https://t.co/9wyCHD42xS #genetherapy #celltherapy
Tweet card summary image
cell.com
Ovarian cancer (OC) patients receive limited benefit from immunotherapy, suggesting a therapeutic need to enhance antitumor immunity. Engineered BiTE-secreting T cells elicit robust antitumor...
1
3
18
@cancer_wales
Cancer Research Wales | Ymchwil Canser Cymru
2 months
The first Cancer Research Wales Brain Tumour Conference is underway today at Sophia Gardens Cricket Ground. We’re honoured to have @JulieMorganLAB join us for the opening address. #BrainTumourConference
0
2
7
@cancer_wales
Cancer Research Wales | Ymchwil Canser Cymru
2 months
Rydym wedi cael diwrnod gwych yng Nghynhadledd Tiwmorau’r Ymennydd Ymchwil Canser Cymru! Drwy ddod â gwyddonwyr, clinigwyr a niwro-lawfeddygon o bob cwr o Gymru ynghyd ac eu cefnogi, byddwn yn darparu llwyfan i ysgogi darganfyddiad a chreadigrwydd. #CynhadleddTiwmoraurYmenydd
0
1
2
@cancer_wales
Cancer Research Wales | Ymchwil Canser Cymru
2 months
📸 We’ve had an amazing day at the Cancer Research Wales Brain Tumour Conference! By bringing together and supporting scientists, clinicians and neurosurgeons from across Wales, we will provide a platform to drive forward discovery and innovation #BrainTumourConference
1
1
2
@cancer_wales
Cancer Research Wales | Ymchwil Canser Cymru
2 months
Well done to all our fantastic Brain Tumour Conference award winners! Llongyfarchiadau i enillwyr y gwobrau gwych yn ein Cynhadledd Tiwmorau’r Ymenydd. #BrainTumourConference | #CynhadleddTiwmorYrYmennydd
0
1
4
@theWCRC
Wales Cancer Research Centre
2 months
Proud to be part of the Cardiff Cancer Research Partnership (CCRP) a collaboration between @VelindreTrust @cardiffuni and @CV_UHB that launched last week. On #WorldCancerResearchDay it is more important than ever to recognise the strength in working together:
0
2
4
@theWCRC
Wales Cancer Research Centre
2 months
We were delighted to join the CPG for Medical Research event at the @SeneddWales, where we met with @PeterFox61 & @MikeHedgesAM. Both were very happy to meet our researchers and hear about the vital work they do to improve cancer outcomes in Wales. 🧬✨ #CancerResearch #Senedd
0
3
6
@theWCRC
Wales Cancer Research Centre
2 months
Yn falch o fod yn rhan o Bartneriaeth Ymchwil Canser Caerdydd (CCRP), cydweithrediad rhwng @VelindreTrust @cardiffuni a @CV_UHB a lansiwyd yr wythnos diwethaf. Ar #DiwrnodYmchwilCanserYByd, mae'n bwysicach nag erioed cydnabod cryfder cydweithio:
0
1
2
@alanlparker
Alan Parker
3 months
Potential GW4 funded 4 year PhD project for October 2026 start adopting machine learning to develop precision virotherapies - with co-supervisors Yukun Lai, Marieke Pingen, Kerry Wadey and Julian Fischer. Come, make some smart viruses with us! https://t.co/LvZetH8dDK
gw4biomed.ac.uk
Project Code MRCIIAR26Ca Parker Project Type Wet lab Research Theme Infection, Immunity, Antimicrobial Resistance and Repair Project Summary Download Summary The Viral ImmunoTherapies and Advanced...
0
7
8
@AccessionTX
Accession Therapeutics
2 months
At #CICON2025 we’re sharing new data on TROCEPT, our tumour-targeted immunotherapy. •Tumour selectivity: Harnesses αvβ6 integrin to deliver >100x more virus to tumours than to the liver •Local immune activation: TROCEPT-01 (ATTR-01) expresses anti-PD-L1 inside tumours, not
Tweet card summary image
accessiontherapeutics.com
Accession Therapeutics is pleased to announce that five abstracts showcasing the company’s TROCEPT cancer immunotherapy platform have been accepted for presentation at three leading international...
0
2
3
@alanlparker
Alan Parker
3 months
If Carlsberg did #PhD students….immense congratulations to DR Emma Swift on absolutely acing your viva and producing an incredible thesis! A huge volume of important work! Many thanks to examiners Stu Nicklin (Uni of Glasgow) and Magda Meissner for examining! Top job, Dr Swift!
2
1
11
@RBayliss2023
Dr Rebecca Bayliss
3 months
If your still interested in submitting an abstract, there's still time! As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies @emilyanne611 Interested in contributing?
0
0
0
@alanlparker
Alan Parker
4 months
If you’re visiting #Eisteddfodd today, do speak to the awesome @LunedBadder representing @cardiffuni, the @virustinkerer lab & @ResearchWales Wales Applied Virology Unit (WAVU), explaining how we develop “#SmartViruses” to treat #Cancer. You can even make a virus of your own!
0
6
12
@virustinkerer
Viral ImmunoTherapies & Advanced therapeutics Lab.
4 months
A short thread about our new paper just published in Molecular Therapy Oncology. Terrific work from first author @RBayliss2023 👏👏
@alanlparker
Alan Parker
4 months
Delighted to share our latest work, published in @MolTherapy Onc https://t.co/eSYO8BNIO0 We describe the development of a suite of avB6 specific oncolytic adenoviruses expressing potent bi-specific immune cell activators designed to immunologically "heat up" tumours.
0
3
5
@alanlparker
Alan Parker
4 months
Delighted to share our latest work, published in @MolTherapy Onc https://t.co/eSYO8BNIO0 We describe the development of a suite of avB6 specific oncolytic adenoviruses expressing potent bi-specific immune cell activators designed to immunologically "heat up" tumours.
Tweet card summary image
cell.com
Virotherapies can deliver anti-cancer therapeutics directly to tumors. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumor cells resulting in...
2
4
17
@alanlparker
Alan Parker
4 months
@RBayliss2023 @LunedBadder And of course, thank you to @CR_UK who supported this important work and whose funding helped push our "precision virotherapy" to first in human evaluation in the ATTEST trial of ATTR-01. To learn more about our clinical trial agent see this animation -
0
2
5
@RBayliss2023
Dr Rebecca Bayliss
4 months
Over the moon our research showing the targeted delivery of bispecific immune cell activators to tumour cells induces immune cell activation and tumour cell killing is published @MolTherapy oncology 🥳.
Tweet card summary image
cell.com
Virotherapies can deliver anti-cancer therapeutics directly to tumors. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumor cells resulting in...
0
1
2